Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)

British Journal of Haematology

Volumn 82, Issue 1, 1992, Pages 87-93

  Mannucci, Pier Mannuccio ^a   And, Donato Bettega ^a   Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOPHILIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SIDE EFFECT; TACHYPHYLAXIS; VON WILLEBRAND DISEASE;

ADULT; ANTIGENS; BLEEDING TIME; DESMOPRESSIN; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMAN; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; TACHYPHYLAXIS; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND DISEASE;

EID: 0026713114     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1992.tb04598.x     Document Type: Article

References (18)

1. Heraodynamic and coagulation responses to 1‐desamino‐8‐D‐arginine vasopressin in patients with congenital nephrogenic diabetes insipldus
2. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor
3. Response of patients with mild and moderate hemophilia A and von Willebrand disease to treatment with desmopressin
4. A new vasopressin analogue and fibrinolysis
5. DDAVP in haemophilia
6. Desmopressin (DDAVP) for treatment of disorders of hemostasis
7. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders
8. Heterogeneity of type I von Willebrand disease. Evidence for a subgroup with an abnormal von Willebrand factor
9. DDAVP: a new pharmacological approach to the management of haemophilia and von Willebrand disease
10. DDAVP in haemophilia
11. Evaluation of the effectiveness of DDAVP in surgery and bleeding episodes in hemophilia and von Willebrand's disease. A study of 43 patients
12. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A
13. Hyper‐responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intraplatelet von Willebrand factor
14. Hyponatremia and seizures in young children given DDAVP
15. DDAVP and epinephrine induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa
16. DDAVP in von Willebrand disease: repeated administration and the behaviour of the bleeding time
17. Severe hyponatremia after repeated intravenous administration of desmopressin
18. Relation of von Willebrand factor to bleeding time